Application 078739
- Type
- ANDA
- Sponsor
- SANDOZ
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | TABLET, ORALLY DISINTEGRATING;ORAL | EQ 5MG BASE | No | No |
| 002 | RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | TABLET, ORALLY DISINTEGRATING;ORAL | EQ 10MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0781-5425 | Rizatriptan Benzoate | rizatriptan benzoate | Sandoz Inc | ANDA | Current |
| 0781-5425 | Rizatriptan Benzoate | rizatriptan benzoate | Sandoz Inc | ANDA | Current |
| 0781-5426 | Rizatriptan Benzoate | rizatriptan benzoate | Sandoz Inc | ANDA | Current |
| 0781-5426 | Rizatriptan Benzoate | rizatriptan benzoate | Sandoz Inc | ANDA | Current |